Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Niveau de preuve du suivi therapeutique pharmacologique de la ribavirine.
Solas C, Paré M, Quaranta S, Stanke-Labesque F; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Francaise de Pharmacologie et de Thérapeutique. Solas C, et al. Among authors: quaranta s. Therapie. 2011 May-Jun;66(3):221-30. doi: 10.2515/therapie/2011036. Therapie. 2011. PMID: 27393202 French.
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients.
Solas C, Simon N, Drogoul MP, Quaranta S, Frixon-Marin V, Bourgarel-Rey V, Brunet C, Gastaut JA, Durand A, Lacarelle B, Poizot-Martin I. Solas C, et al. Among authors: quaranta s. Br J Clin Pharmacol. 2007 Sep;64(3):353-62. doi: 10.1111/j.1365-2125.2007.02903.x. Epub 2007 May 22. Br J Clin Pharmacol. 2007. PMID: 17517050 Free PMC article.
[Evidence-based therapeutic drug monitoring for nevirapine].
Muret P, Piedoux S, Solas C, Quaranta S; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Muret P, et al. Among authors: quaranta s. Therapie. 2011 May-Jun;66(3):187-95. doi: 10.2515/therapie/2011030. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819802 Review. French.
[Evidence-based therapeutic drug monitoring for ribavirine].
Solas C, Paré M, Quaranta S, Stanke-Labesque F; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Solas C, et al. Among authors: quaranta s. Therapie. 2011 May-Jun;66(3):221-30. doi: 10.2515/therapie/2011036. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819806 Review. French.
101 results